WallStSmart
BCTX

Briacell Therapeutics Corp

NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY

$4.18
+3.98% today

Updated 2026-04-30

Market cap
$28.13M
P/E ratio
P/S ratio
EPS (TTM)
$-14.42
Dividend yield
52W range
$4 – $50
Volume
0.2M

Briacell Therapeutics Corp (BCTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+15.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-10.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-12.9%
2025-12-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-11$-2.58$3.81$4.30+12.9%
2025-12-12$-4.35$10.31$8.98-12.9%
2025-10-15$-9.24+23.7%$11.42$12.32+7.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-01-31$-2.58
2025-10-31$-4.35
2025-07-31$-12.11$-9.24+23.7%$225340.00+894.0%
2025-04-30$-1.76$-1.64+6.8%
2025-01-31$-1.94$-2.33-20.1%
2024-10-31$-0.30$-0.22+26.7%
2024-07-31$-0.46$-0.07+84.8%$22671.00
2024-04-30$-0.55$0.11+120.0%
2024-01-31$-0.20$-0.71-255.0%
2023-10-31$-0.18$-0.50-177.8%
2023-07-31$-0.39$-0.15+61.5%

Frequently asked questions

Has Briacell Therapeutics Corp beaten earnings estimates?
Briacell Therapeutics Corp has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +15.3% over the last 2 quarters.
How does BCTX stock react to earnings?
BCTX stock has moved an average of +2.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.